Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Cost and Utilization Of Stored Autologous PBSC To Support Tandem ASCT In MM Patients In The Era Of Novel Agent Therapy

Colin Phipps, MD, Michael L. Linenberger, MD, Damian J. Green, MD, M. Corinna Palanca-Wessels, MD, PhD, Pamela S. Becker, MD, PhD, Laura S. Connelly-Smith, MBBCh, DM, Nicholas Burwick, MD, Zandra K. Klippel, MD, William I. Bensinger, MD, Leona Holmberg, MD, PhD, Edward N. Libby, III, MD

Blood (2013) 122 (21): 4507.

https://doi.org/10.1182/blood.V122.21.4507.4507

Published: 2013

Journal Articles

Larger Numbers of Donor Naïve CD8+ T-Cells and Plasmacytoid Dendritic Cell Precursors In Allogeneic BM Grafts From Unrelated Donors Are Associated with Improved Survival: Results From BMT CTN 0201

Edmund K Waller, MD PhD, Wayne A.C. Harris, Steven Devine, David L. Porter, MD, Shin Mineishi, MD, John M. McCarty, MD, Corina E Gonzalez, MD, Thomas R Spitzer, MD, Oleg I. Krijanovski, PhD, MD, Michael L. Linenberger, MD, Ann Woolfrey, MD, Alan Howard, PhD, Cathy Gurgol, Brent R. Logan, PhD, Dennis L Confer, MD, Claudio Anasetti, MD

Blood (2011) 118 (21): 1004.

https://doi.org/10.1182/blood.V118.21.1004.1004

Published: 2011

Journal Articles

International Working Group Scores Predict Post-Transplant Outcomes In Patients with Myelofibrosis

Bart Lee Scott, MD, Ted A. Gooley, PhD, Michael L. Linenberger, MD, Brenda M. Sandmaier, MD, David Myerson, MD, Thomas Chauncey, MD, Frederick R. Appelbaum, MD, H. Joachim Deeg, MD

Blood (2010) 116 (21): 3085.

https://doi.org/10.1182/blood.V116.21.3085.3085

Published: 2010

Journal Articles

The Effective Use of Plerixafor as a Real-Time Rescue Strategy for Patients with Poorly Mobilizing Autologous CD34+ Cells

Ajay K Gopal, MD, Mehdi Karami, PharmD, JoAL Mayor, PharmD, Mylene Macabeo, RN, Michael L. Linenberger, MD, William Bensinger, MD, Leona Holmberg, MD., PhD

Blood (2010) 116 (21): 2251.

https://doi.org/10.1182/blood.V116.21.2251.2251

Published: 2010

Journal Articles

Effect of Peripheral Blood Stem Cell (PBSC) Graft Composition on Graft Versus Host Disease (GVHD) and Mortality After Allogeneic Transplantation

Shelly Heimfeld, PhD, Ted Gooley, Mary Flowers, MD, Frederic Baron, MD, PhD, Paul J. Martin, MD, Michael L. Linenberger, MD, Rainer F. Storb, MD, Frederick R. Appelbaum, MD, Brenda M. Sandmaier, MD

Blood (2010) 116 (21): 676.

https://doi.org/10.1182/blood.V116.21.676.676

Published: 2010

NARROW

Cost and Utilization Of Stored Autologous PBSC To Support Tandem ASCT In MM Patients In The Era Of Novel Agent Therapy

Larger Numbers of Donor Naïve CD8+ T-Cells and Plasmacytoid Dendritic Cell Precursors In Allogeneic BM Grafts From Unrelated Donors Are Associated with Improved Survival: Results From BMT CTN 0201

International Working Group Scores Predict Post-Transplant Outcomes In Patients with Myelofibrosis

The Effective Use of Plerixafor as a Real-Time Rescue Strategy for Patients with Poorly Mobilizing Autologous CD34+ Cells

Effect of Peripheral Blood Stem Cell (PBSC) Graft Composition on Graft Versus Host Disease (GVHD) and Mortality After Allogeneic Transplantation

Email alerts

ASH Publications

American Society of Hematology

Cost and Utilization Of Stored Autologous PBSC To Support Tandem ASCT In MM Patients In The Era Of Novel Agent Therapy

Larger Numbers of Donor Naïve CD8+ T-Cells and Plasmacytoid Dendritic Cell Precursors In Allogeneic BM Grafts From Unrelated Donors Are Associated with Improved Survival: Results From BMT CTN 0201

International Working Group Scores Predict Post-Transplant Outcomes In Patients with Myelofibrosis

The Effective Use of Plerixafor as a Real-Time Rescue Strategy for Patients with Poorly Mobilizing Autologous CD34+ Cells

Effect of Peripheral Blood Stem Cell (PBSC) Graft Composition on Graft Versus Host Disease (GVHD) and Mortality After Allogeneic Transplantation

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only